Susan Morgan-Lappe
9Patents
5h-index
21Co-inventors
59Inventor score
Filing activity: Apr 28, 2009 → Dec 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9029508B2 | Dual variable domain immunoglobulins and uses thereof | Emerging Cross-Sectional Technologies | 53 | Active |
| US9115195B2 | Therapeutic DLL4 binding proteins | Chemistry; Metallurgy | 14 | Active |
| US9132190B2 | Therapeutic DLL4 binding proteins | Chemistry; Metallurgy | 14 | Active |
| US8623358B2 | Therapeutic DLL4 binding proteins | Chemistry; Metallurgy | 10 | Active |
| US9469689B2 | Therapeutic DLL4 binding proteins | Chemistry; Metallurgy | 10 | Active |
| US9469688B2 | Therapeutic DLL4 binding proteins | Chemistry; Metallurgy | 2 | Active |
| US10195209B2 | Anti-huLRRC15 antibody drug conjugates and methods for their use | Chemistry; Metallurgy | 1 | Active |
| US10188660B2 | Anti-huLRRC15 antibody drug conjugates and methods for their use | Chemistry; Metallurgy | 1 | Active |
| US11045480B2 | Anti-huLRRC15 antibody drug conjugates and methods for their use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.